SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 200.52 |
Enterprise Value ($M) | 157.10 |
Book Value ($M) | 196.89 |
Book Value / Share | 6.32 |
Price / Book | 1.02 |
NCAV ($M) | 171.19 |
NCAV / Share | 5.50 |
Price / NCAV | 1.17 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.38 |
Return on Assets (ROA) | -0.51 |
Return on Equity (ROE) | -0.56 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 12.75 |
Current Ratio | 12.75 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 188.98 |
Assets | 214.68 |
Liabilities | 17.79 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Chione Ltd | 17.30 | -0.21 | |
13G/A | Perceptive Advisors Llc | 17.40 | 78.23 | |
13D/A | Ra Capital Management, L.p. | 27.10 | 73.52 | |
13G/A | Citadel Advisors Llc | 7.40 | ||
13G/A | Marshall Wace North America L.P. | 2.70 | -51.16 | |
13G/A | Sands Capital Ventures, LLC | 7.40 | -0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
9,362 | 22,234 | 42.11 | |
5,974 | 21,162 | 28.23 | |
6,831 | 24,462 | 27.92 | |
10,362 | 42,658 | 24.29 | |
15,744 | 68,320 | 23.04 | |
(click for more detail) |
Similar Companies | |
---|---|
ACET – Adicet Bio, Inc. | ACIU – AC Immune SA |
ADMA – ADMA Biologics, Inc. | AFMD – Affimed N.V. |
Financial data and stock pages provided by
Fintel.io